hemorrhoids with bleeding
Conditions
Interventions
Experimental group:Polidocanol diluent (3% polidocanol 2ml + normal saline 8ml) is injected by endoscope for sclerotherapy
Control group:Polidocanol foam (3% polydocanol 2ml+ air 8ml) is injected by endoscope for sclerotherapy
Sponsors
The Third People’s Hospital of Chengdu
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Male or female, aged 18-75 years (including 18 and 75 years); (2) Grade I-III internal hemorrhoids with symptoms including bleeding; (3) Voluntarily participate and sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Grade IV internal hemorrhoids, mixed hemorrhoids and external hemorrhoids; (2) Internal hemorrhoids of grade I to III are accompanied by incarceration, thrombosis, ulceration, infection and other complications; (3) Severe heart, brain, lung, liver, kidney failure can not tolerate endoscopic treatment; (4) Perianal infectious disease, anal fistula, radiotherapy history and inflammatory bowel disease during active period; (5)Ppatients allergic to Polidocanol ; (6) Pregnant women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effectiveness of the treatment on bleeding control is evaluated at 12 and 24 weeks post-operation;The effectiveness of prolapse improvement is evaluated at 12 and 24 weeks after surgery;Endoscopy is reviewed 24 weeks after surgery and recurrence of internal hemorrhoid is assessed; | — |
Countries
China
Contacts
Public ContactSHAN Jing
The Third People’s Hospital of Chengdu
Outcome results
None listed